BKV vs DK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits a weak Piotroski F-Score of 4/9, indicating borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong recent earnings and revenue growth, elevated valuation metrics, declining insider sentiment, and weak technicals suggest caution. The stock trades significantly above both the Graham Number ($14.69) and intrinsic value ($14.16), implying a premium priced on future growth. While analyst consensus is strong_buy, insider selling and deteriorating short-term EPS momentum present countervailing risks.
Delek US Holdings exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. The company is dangerously over-leveraged with a Debt/Equity ratio of 6.49, far exceeding the sector average of 1.46, and faces liquidity risks with a Current Ratio of 0.82. Furthermore, the dividend is unsustainable with a payout ratio of 308.33%, suggesting it is funded by debt or cash reserves rather than earnings. Despite a bullish analyst consensus and a low PEG ratio, the combination of insider selling and deteriorating deterministic scores suggests a high-risk profile.
Compare Another Pair
Related Comparisons
BKV vs DK: Head-to-Head Comparison
This page compares BKV Corporation (BKV) and Delek US Holdings, Inc. (DK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.